KY HB12 | 2020 | Regular Session
Status
Spectrum: Bipartisan Bill
Status: Engrossed on February 20 2020 - 50% progression, died in committee
Action: 2020-04-15 - recommitted to Banking & Insurance (S)
Pending: Senate Banking and Insurance Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on February 20 2020 - 50% progression, died in committee
Action: 2020-04-15 - recommitted to Banking & Insurance (S)
Pending: Senate Banking and Insurance Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Amend KRS 304-17A.148 to cap the cost sharing requirements for prescription insulin at $100 per 30 day supply; EFFECTIVE January 1, 2021.
Title
AN ACT relating to prescription insulin.
Sponsors
Roll Calls
2020-02-19 - House - House: Third Reading RCS# 123 (Y: 92 N: 0 NV: 0 Abs: 6) [PASS]
History
Date | Chamber | Action |
---|---|---|
2020-04-15 | Senate | recommitted to Banking & Insurance (S) |
2020-03-18 | Senate | 2nd reading, to Rules |
2020-03-17 | Senate | reported favorably, 1st reading, to Calendar with Committee Substitute (1) |
2020-02-26 | Senate | to Banking & Insurance (S) |
2020-02-20 | Senate | received in Senate |
2020-02-19 | House | 3rd reading, passed 92-0 with Committee Substitute (1) and floor amendment (1) |
2020-02-18 | House | floor amendment (1) filed to Committee Substitute |
2020-02-18 | House | posted for passage in the Regular Orders of the Day for Wednesday, February 19, 2020 |
2020-02-14 | House | 2nd reading, to Rules |
2020-02-13 | House | reported favorably, 1st reading, to Calendar with Committee Substitute (1) |
2020-01-28 | House | posted in committee |
2020-01-13 | House | posted in committee |
2020-01-07 | House | to Health and Family Services (H) |
2020-01-07 | House | introduced in House |
2019-06-04 | House | Prefiled by the sponsor(s). |